APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kinesin Like Protein KIF11

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Kinesin Like Protein KIF11 Market Outlook and Growth Opportunities 2026

19 December 2025190 pages

Choose your research edition.

Industry ResearchKinesin Like Protein KIF11 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Kinesin Like Protein KIF11 Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Kinesin Like Protein KIF11 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kinesin Like Protein KIF11 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Kinesin Like Protein KIF11 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Kinesin Like Protein KIF11 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Kinesin Like Protein KIF11 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Kinesin Like Protein KIF11 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kinesin Like Protein KIF11 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Kinesin Like Protein KIF11 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Kinesin Like Protein KIF11 market include 4SC AG, Alnylam Pharmaceuticals, Inc., Array BioPharma Inc., Kyowa Hakko Kirin, Pfizer Inc., Merck & Co., Inc. and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Kinesin Like Protein KIF11 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Kinesin Like Protein KIF11 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Kinesin Like Protein KIF11 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Kinesin Like Protein KIF11 market.

Kinesin Like Protein KIF11 Segment by Company

4SC AG

Alnylam Pharmaceuticals, Inc.

Array BioPharma Inc.

Kyowa Hakko Kirin

Pfizer Inc.

Merck & Co., Inc.

Novartis AG

Kinesin Like Protein KIF11 Segment by Type

BQS-481

BIND-267

ALN-VSP

4SC-205

Others

Kinesin Like Protein KIF11 Segment by Application

Kidney Cancer

Breast Cancer

Colorectal Cancer

Liver Cancer

Others

Kinesin Like Protein KIF11 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Kinesin Like Protein KIF11 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Kinesin Like Protein KIF11 key companies, revenue, market share, and recent developments.

3. To split the Kinesin Like Protein KIF11 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Kinesin Like Protein KIF11 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Kinesin Like Protein KIF11 significant trends, drivers, influence factors in global and regions.

6. To analyze Kinesin Like Protein KIF11 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kinesin Like Protein KIF11 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kinesin Like Protein KIF11 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kinesin Like Protein KIF11.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Kinesin Like Protein KIF11 industry.

Chapter 3: Detailed analysis of Kinesin Like Protein KIF11 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Kinesin Like Protein KIF11 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Kinesin Like Protein KIF11 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Kinesin Like Protein KIF11 Industry Trends Table 2. Kinesin Like Protein KIF11 Industry Drivers Table 3. Kinesin Like Protein KIF11 Industry Opportunities and Challenges Table 4. Kinesin Like Protein KIF11 Industry Restraints Table 5. Global Kinesin Like Protein KIF11 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Kinesin Like Protein KIF11 Revenue Share by Company (2021-2026) Table 7. Global Kinesin Like Protein KIF11 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Kinesin Like Protein KIF11 Key Company Manufacturing Base & Headquarters Table 9. Global Kinesin Like Protein KIF11 Company, Product Type & Application Table 10. Global Kinesin Like Protein KIF11 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Kinesin Like Protein KIF11 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of BQS-481 Table 15. Significant Companies of BIND-267 Table 16. Significant Companies of ALN-VSP Table 17. Significant Companies of 4SC-205 Table 18. Significant Companies of Others Table 19. Global Kinesin Like Protein KIF11 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Kinesin Like Protein KIF11 Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Kinesin Like Protein KIF11 Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Kinesin Like Protein KIF11 Sales Value Share by Type (2021-2026) Table 23. Global Kinesin Like Protein KIF11 Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Kidney Cancer Table 25. Significant Companies of Breast Cancer Table 26. Significant Companies of Colorectal Cancer Table 27. Significant Companies of Liver Cancer Table 28. Significant Companies of Others Table 29. Global Kinesin Like Protein KIF11 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Kinesin Like Protein KIF11 Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Kinesin Like Protein KIF11 Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Kinesin Like Protein KIF11 Sales Value Share by Application (2021-2026) Table 33. Global Kinesin Like Protein KIF11 Sales Value Share by Application (2027-2032) Table 34. Global Kinesin Like Protein KIF11 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Kinesin Like Protein KIF11 Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Kinesin Like Protein KIF11 Sales Value Share by Region (2021-2026) Table 37. Global Kinesin Like Protein KIF11 Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Kinesin Like Protein KIF11 Sales Value Share by Region (2027-2032) Table 39. Global Kinesin Like Protein KIF11 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Kinesin Like Protein KIF11 Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Kinesin Like Protein KIF11 Sales Value Market Share by Country (2021-2026) Table 42. Global Kinesin Like Protein KIF11 Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Kinesin Like Protein KIF11 Sales Value Market Share by Country (2027-2032) Table 44. 4SC AG Company Information Table 45. 4SC AG Business Overview Table 46. 4SC AG Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. 4SC AG Kinesin Like Protein KIF11 Product Portfolio Table 48. 4SC AG Recent Development Table 49. Alnylam Pharmaceuticals, Inc. Company Information Table 50. Alnylam Pharmaceuticals, Inc. Business Overview Table 51. Alnylam Pharmaceuticals, Inc. Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Alnylam Pharmaceuticals, Inc. Kinesin Like Protein KIF11 Product Portfolio Table 53. Alnylam Pharmaceuticals, Inc. Recent Development Table 54. Array BioPharma Inc. Company Information Table 55. Array BioPharma Inc. Business Overview Table 56. Array BioPharma Inc. Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Array BioPharma Inc. Kinesin Like Protein KIF11 Product Portfolio Table 58. Array BioPharma Inc. Recent Development Table 59. Kyowa Hakko Kirin Company Information Table 60. Kyowa Hakko Kirin Business Overview Table 61. Kyowa Hakko Kirin Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Kyowa Hakko Kirin Kinesin Like Protein KIF11 Product Portfolio Table 63. Kyowa Hakko Kirin Recent Development Table 64. Pfizer Inc. Company Information Table 65. Pfizer Inc. Business Overview Table 66. Pfizer Inc. Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pfizer Inc. Kinesin Like Protein KIF11 Product Portfolio Table 68. Pfizer Inc. Recent Development Table 69. Merck & Co., Inc. Company Information Table 70. Merck & Co., Inc. Business Overview Table 71. Merck & Co., Inc. Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck & Co., Inc. Kinesin Like Protein KIF11 Product Portfolio Table 73. Merck & Co., Inc. Recent Development Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Kinesin Like Protein KIF11 Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis AG Kinesin Like Protein KIF11 Product Portfolio Table 78. Novartis AG Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Kinesin Like Protein KIF11 Product Image Figure 2. Global Kinesin Like Protein KIF11 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kinesin Like Protein KIF11 Market Size (2021-2032) & (US$ Million) Figure 4. Global Kinesin Like Protein KIF11 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. BQS-481 Image Figure 8. BIND-267 Image Figure 9. ALN-VSP Image Figure 10. 4SC-205 Image Figure 11. Others Image Figure 12. Global Kinesin Like Protein KIF11 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Kinesin Like Protein KIF11 Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Kinesin Like Protein KIF11 Sales Value Share by Type (2021-2032) Figure 15. Kidney Cancer Image Figure 16. Breast Cancer Image Figure 17. Colorectal Cancer Image Figure 18. Liver Cancer Image Figure 19. Others Image Figure 20. Global Kinesin Like Protein KIF11 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Kinesin Like Protein KIF11 Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Kinesin Like Protein KIF11 Sales Value Share by Application (2021-2032) Figure 23. Global Kinesin Like Protein KIF11 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Kinesin Like Protein KIF11 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Kinesin Like Protein KIF11 Sales Value (2021-2032) & (US$ Million) Figure 26. North America Kinesin Like Protein KIF11 Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Kinesin Like Protein KIF11 Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Kinesin Like Protein KIF11 Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Kinesin Like Protein KIF11 Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Kinesin Like Protein KIF11 Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Kinesin Like Protein KIF11 Sales Value (2021-2032) & (US$ Million) Figure 32. South America Kinesin Like Protein KIF11 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Kinesin Like Protein KIF11 Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Kinesin Like Protein KIF11 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • BQS-481
  • BIND-267
  • ALN-VSP
  • 4SC-205
  • Others
Applications
  • Kidney Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Others
Companies covered
  • 4SC AG
  • Alnylam Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Kyowa Hakko Kirin
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Kinesin Like Protein KIF11 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Kinesin Like Protein KIF11 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Kinesin Like Protein KIF11 Market Dynamics
  1. 2.1 Kinesin Like Protein KIF11 Industry Trends
  2. 2.2 Kinesin Like Protein KIF11 Industry Drivers
  3. 2.3 Kinesin Like Protein KIF11 Industry Opportunities and Challenges
  4. 2.4 Kinesin Like Protein KIF11 Industry Restraints
3 Kinesin Like Protein KIF11 Market by Company
  1. 3.1 Global Kinesin Like Protein KIF11 Company Revenue Ranking in 2025
  2. 3.2 Global Kinesin Like Protein KIF11 Revenue by Company (2021-2026)
  3. 3.3 Global Kinesin Like Protein KIF11 Company Ranking (2024-2026)
  4. 3.4 Global Kinesin Like Protein KIF11 Company Manufacturing Base and Headquarters
  5. 3.5 Global Kinesin Like Protein KIF11 Company Product Type and Application
  6. 3.6 Global Kinesin Like Protein KIF11 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Kinesin Like Protein KIF11 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Kinesin Like Protein KIF11 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Kinesin Like Protein KIF11 Market by Type
  1. 4.1 Kinesin Like Protein KIF11 Type Introduction
  2. 4.1.1 BQS-481
  3. 4.1.2 BIND-267
  4. 4.1.3 ALN-VSP
  5. 4.1.4 4SC-205
  6. 4.1.5 Others
  7. 4.2 Global Kinesin Like Protein KIF11 Sales Value by Type
  8. 4.2.1 Global Kinesin Like Protein KIF11 Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Kinesin Like Protein KIF11 Sales Value by Type (2021-2032)
  10. 4.2.3 Global Kinesin Like Protein KIF11 Sales Value Share by Type (2021-2032)
5 Kinesin Like Protein KIF11 Market by Application
  1. 5.1 Kinesin Like Protein KIF11 Application Introduction
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Colorectal Cancer
  5. 5.1.4 Liver Cancer
  6. 5.1.5 Others
  7. 5.2 Global Kinesin Like Protein KIF11 Sales Value by Application
  8. 5.2.1 Global Kinesin Like Protein KIF11 Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Kinesin Like Protein KIF11 Sales Value by Application (2021-2032)
  10. 5.2.3 Global Kinesin Like Protein KIF11 Sales Value Share by Application (2021-2032)
6 Kinesin Like Protein KIF11 Regional Value Analysis
  1. 6.1 Global Kinesin Like Protein KIF11 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Kinesin Like Protein KIF11 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Kinesin Like Protein KIF11 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Kinesin Like Protein KIF11 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Kinesin Like Protein KIF11 Sales Value (2021-2032)
  7. 6.3.2 North America Kinesin Like Protein KIF11 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Kinesin Like Protein KIF11 Sales Value (2021-2032)
  10. 6.4.2 Europe Kinesin Like Protein KIF11 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Kinesin Like Protein KIF11 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Kinesin Like Protein KIF11 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Kinesin Like Protein KIF11 Sales Value (2021-2032)
  16. 6.6.2 South America Kinesin Like Protein KIF11 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Kinesin Like Protein KIF11 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Kinesin Like Protein KIF11 Sales Value Share by Country, 2025 VS 2032
7 Kinesin Like Protein KIF11 Country-level Value Analysis
  1. 7.1 Global Kinesin Like Protein KIF11 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Kinesin Like Protein KIF11 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Kinesin Like Protein KIF11 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Kinesin Like Protein KIF11 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Kinesin Like Protein KIF11 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Kinesin Like Protein KIF11 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Kinesin Like Protein KIF11 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC AG
  2. 8.1.1 4SC AG Company Information
  3. 8.1.2 4SC AG Business Overview
  4. 8.1.3 4SC AG Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 4SC AG Kinesin Like Protein KIF11 Product Portfolio
  6. 8.1.5 4SC AG Recent Developments
  7. 8.2 Alnylam Pharmaceuticals, Inc.
  8. 8.2.1 Alnylam Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Alnylam Pharmaceuticals, Inc. Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alnylam Pharmaceuticals, Inc. Kinesin Like Protein KIF11 Product Portfolio
  12. 8.2.5 Alnylam Pharmaceuticals, Inc. Recent Developments
  13. 8.3 Array BioPharma Inc.
  14. 8.3.1 Array BioPharma Inc. Company Information
  15. 8.3.2 Array BioPharma Inc. Business Overview
  16. 8.3.3 Array BioPharma Inc. Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Array BioPharma Inc. Kinesin Like Protein KIF11 Product Portfolio
  18. 8.3.5 Array BioPharma Inc. Recent Developments
  19. 8.4 Kyowa Hakko Kirin
  20. 8.4.1 Kyowa Hakko Kirin Company Information
  21. 8.4.2 Kyowa Hakko Kirin Business Overview
  22. 8.4.3 Kyowa Hakko Kirin Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kyowa Hakko Kirin Kinesin Like Protein KIF11 Product Portfolio
  24. 8.4.5 Kyowa Hakko Kirin Recent Developments
  25. 8.5 Pfizer Inc.
  26. 8.5.1 Pfizer Inc. Company Information
  27. 8.5.2 Pfizer Inc. Business Overview
  28. 8.5.3 Pfizer Inc. Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Inc. Kinesin Like Protein KIF11 Product Portfolio
  30. 8.5.5 Pfizer Inc. Recent Developments
  31. 8.6 Merck & Co., Inc.
  32. 8.6.1 Merck & Co., Inc. Company Information
  33. 8.6.2 Merck & Co., Inc. Business Overview
  34. 8.6.3 Merck & Co., Inc. Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck & Co., Inc. Kinesin Like Protein KIF11 Product Portfolio
  36. 8.6.5 Merck & Co., Inc. Recent Developments
  37. 8.7 Novartis AG
  38. 8.7.1 Novartis AG Company Information
  39. 8.7.2 Novartis AG Business Overview
  40. 8.7.3 Novartis AG Kinesin Like Protein KIF11 Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis AG Kinesin Like Protein KIF11 Product Portfolio
  42. 8.7.5 Novartis AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst